The treatment of active chronic hepatitis with 6-mercaptopurine and azathioprine.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002908:Chronic Disease; D005260:Female; D005500:Follow-Up Studies; D006505:Hepatitis / Q000188:drug therapy*; D006801:Humans; D008099:Liver / Q000187:drug effects; D008111:Liver Function Tests; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D011379:Prognosis
D015122:Mercaptopurine; D001379:Azathioprine; D011241:Prednisone